Strain AI vs OPTIS Mobile Next Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Strain AI

by Strain AI

OPTIS Mobile Next Imaging

by Abbott Medical

AI Verdict

Tool A, Strain AI, is designed for non-invasive diagnostic assessment of heart function by analyzing cardiac ultrasound images to measure Global Longitudinal Strain. In contrast, Tool B, OPTIS Mobile Next Imaging, is an intravascular imaging system that provides high-resolution OCT and coronary physiology measurements to guide interventional PCI procedures. While both utilize AI in cardiology, Strain AI focuses on diagnostic evaluation, whereas OPTIS Mobile Next Imaging is tailored for real-time procedural guidance during invasive interventions.

Choose Strain AI if…

Choose Strain AI if you need a rapid, non-invasive, and quantitative assessment of adult cardiac function using ultrasound. This tool is ideal for screening for early signs of heart failure, monitoring cardiotoxicity, or evaluating hypertrophy directly at the point of care without requiring an internet connection.

View Strain AI →

Choose OPTIS Mobile Next Imaging if…

Choose OPTIS Mobile Next Imaging if you require precise intravascular imaging and coronary physiology measurements to guide percutaneous coronary intervention (PCI) procedures in a cath lab. This system is best suited for interventional cardiologists seeking real-time, high-resolution OCT and FFR/RFR data to optimize stent placement and enhance decision-making during complex coronary interventions.

View OPTIS Mobile Next Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Strain AI	OPTIS Mobile Next Imaging
Deployment	API, Integrations with POS and menu sync platforms (Dutchie, Leafly, Weedmaps, Jane POS, Treez)	On-premise (mobile cart system integrated into catheterization laboratories)
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Strain AI

Strain AI offers on-device AI and operates without an internet connection, simplifying deployment and use in various clinical settings. Its ability to integrate with existing ultrasound devices and provide diagnostic evaluation without manual image interpretation streamlines workflows for a broader user base.

Clinical Value

Tie

Both tools provide significant, FDA-cleared clinical value within cardiology, albeit in different domains. Strain AI aids in the diagnostic assessment of heart function by measuring Global Longitudinal Strain, while OPTIS Mobile Next Imaging guides complex PCI procedures with high-resolution OCT and coronary physiology measurements.

Pricing & Value

Tie

Neither tool provides explicit pricing information, requiring direct contact with the vendor. Without specific cost details, it is impossible to conduct a comparative analysis of their pricing structures or overall value propositions.

Enterprise Readiness

Strain AI

Strain AI explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which provides clear assurances for enterprise data governance. Its on-device, offline deployment further simplifies security and integration considerations for healthcare organizations.

Innovation

OPTIS Mobile Next Imaging

OPTIS Mobile Next Imaging demonstrates a higher degree of integrated innovation by combining high-resolution OCT, coronary physiology measurements (RFR/FFR), and AI on a single, transportable platform. Its simultaneous angio and OCT co-registration, along with a wireless controller, offers a comprehensive and advanced solution for guiding complex PCI procedures.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability or quality of support and documentation for either Strain AI or OPTIS Mobile Next Imaging. Therefore, a comparative assessment is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Strain AI	OPTIS Mobile Next Imaging
Product Name	Strain AI	OPTIS Mobile Next Imaging
Company	Exo	Abbott Medical
Primary Function/Description	AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients.	AI-powered, transportable intravascular imaging system for cath labs, offering high-resolution OCT and coronary physiology measurements to guide PCI procedures with enhanced efficiency and informed decision-making.
Key AI-driven Measurement/Analysis	Measures Global Longitudinal Strain (GLS); assists in detecting heart failure (CHF, HFpEF, HFrEF) and hypertrophy.	High-resolution OCT and coronary physiology measurements (RFR/FFR); faster information display and workflow efficiency via Ultreonu2122 Software.
Target Medical Specialty	Cardiology, Oncology, Radiology	Cardiology
Integration/Connectivity	Integrates with existing ultrasound devices	Seamless and secure integration with cath lab IT systems and DICOM

Videos

Demos, reviews, and walkthroughs featuring Strain AI and OPTIS Mobile Next Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and patient populations each tool is designed to serve?

Strain AI is an FDA-cleared AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), assisting physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. OPTIS Mobile Next Imaging is an AI-powered, transportable intravascular imaging system that offers high-resolution Optical Coherence Tomography (OCT) and coronary physiology measurements to guide Percutaneous Coronary Intervention (PCI) procedures in cath labs.

What specific imaging modalities and quantitative measurements do these tools provide?

Strain AI analyzes cardiac ultrasound images to provide quantitative Global Longitudinal Strain (GLS) measurements. OPTIS Mobile Next Imaging offers high-resolution Optical Coherence Tomography (OCT) intravascular imaging and coronary physiology measurements, such as RFR/FFR, on one platform.

How do these tools integrate into existing clinical workflows and IT infrastructure?

Strain AI features on-device AI, allowing it to operate without an internet connection and integrate with existing ultrasound devices. OPTIS Mobile Next Imaging is a transportable mobile cart system designed for on-premise use in catheterization laboratories, offering seamless and secure integration with cath lab IT systems and DICOM.

What are the connectivity requirements for each system to function effectively?

Strain AI operates without an internet connection due to its on-device AI deployment. OPTIS Mobile Next Imaging requires connections to the boom monitor video, angiography system via Ethernet, and a DICOM server for efficient operation within the cath lab.

How do these tools address regulatory compliance, data security, and privacy (e.g., FDA, HIPAA, BAA)?

Both Strain AI and OPTIS Mobile Next Imaging are FDA-cleared. Strain AI is explicitly HIPAA compliant and has a Business Associate Agreement (BAA). For OPTIS Mobile Next Imaging, it is likely HIPAA compliant, with the responsibility for data handling and associated BAAs typically lying with the healthcare provider.

What medical specialties are primarily targeted by each tool, and what is their scope of application?

Strain AI targets Cardiology, Oncology, and Radiology, focusing on diagnostic evaluation of heart function. OPTIS Mobile Next Imaging is primarily for Cardiology, specifically guiding percutaneous coronary intervention (PCI) procedures.